Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.95 USD | +8.93% | +6.27% | -32.59% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.59% | 200M | |
+8.46% | 220B | |
+14.38% | 196B | |
+26.90% | 152B | |
+33.90% | 114B | |
+3.76% | 66.49B | |
+15.11% | 52.89B | |
+1.93% | 49.48B | |
-4.22% | 38.85B | |
-1.75% | 34.68B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Earnings Flash (NPCE) NEUROPACE Posts Q1 Revenue $18.1M, vs. Street Est of $17.3M